SCHEMBL2864413

SCHEMBL2864413

COC(=O)c1ccc2[nH]nc(-c3cccnc3)c2c1

nearest known ligand 0.60

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAP2K4 P45985 3/20 0.60
CYP19A1 P11511 1/20 0.58
CYP11B1 P15538 1/20 0.58
CYP11B2 P19099 1/20 0.58
LRRK2 Q5S007 2/20 0.55
IDO1 P14902 1/20 0.55
PIM1 P11309 4/20 0.53
NR4A2 P43354 1/20 0.53
DYRK1A Q13627 2/20 0.53
SLC2A1 P11166 1/20 0.52
NEK1 Q96PY6 1/20 0.52
ALDH1A1 P00352 1/20 0.51
CDK7 P50613 1/20 0.50
TTK P33981 1/20 0.49
AXL P30530 1/20 0.49
NTRK1 P04629 1/20 0.48
PIM3 Q86V86 1/20 0.48
PIM2 Q9P1W9 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9986229 0.84 MAPK1 (0.58) MAP2K4
SCHEMBL2863052 0.84 MAP2K4 (0.62) MAP2K4LRRK2IDO1PIM1CDK7
SCHEMBL2860913 0.81 MAP2K4 (0.61) MAP2K4TTKNTRK1
SCHEMBL2866811 0.81 MAP2K4 (0.55) MAP2K4LRRK2TTK
SCHEMBL7809400 0.80 CYP11B1 (0.59) CYP19A1CYP11B1CYP11B2NR4A2SLC2A1
SCHEMBL2861069 0.79 ALPL (0.54) MAP2K4CYP19A1CYP11B1CYP11B2
SCHEMBL12594228 0.79 CYP19A1 (0.54) CYP19A1CYP11B1CYP11B2PIM1NR4A2
SCHEMBL1501529 0.78 KDM4E (0.55) MAP2K4DYRK1AALDH1A1
SCHEMBL2860104 0.78 PIM1 (0.53) MAP2K4CYP19A1CYP11B1CYP11B2LRRK2
SCHEMBL2863569 0.78 LRRK2 (0.56) MAP2K4LRRK2PIM1AXLNTRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7776890-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-17 US disclosed
EP-1380576-B1 1H-INDAZOLE COMPOUNDS INHIBITING JNK EISAI R&D MAN CO LTD (JP) 2009-11-25 EP disclosed
US-20090203691-A1 Novel 1H-indazole compounds OINUMA HITOSHI 2009-08-13 US disclosed
US-7541376-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-02 US disclosed
CN-1300116-C 1H-indazole compounds EISAI CO LTD (JP) 2007-02-14 CN disclosed
US-6982274-B2 1H-indazole compound EISAI CO., LTD. (JP) 2006-01-03 US disclosed
US-20050282880-A1 Novel 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2005-12-22 US disclosed
CN-1512987-A Novel 1H-indazole compound ������������ʽ���� 2004-07-14 CN disclosed
US-20040127538-A1 Novel 1h-indazole compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2004-07-01 US disclosed
EP-1380576-A1 NOVEL 1H-INDAZOLE COMPOUND Eisai Co., Ltd. (JP) 2004-01-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090203691-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 MAP2K4 61/4885CYP19A1 1656/4885CYP11B1 187/4885
US-20040127538-A1 Novel 1h-indazole compound MAPK1, MAPK14, MAPK3 MAP2K4 53/4885CYP19A1 1929/4885CYP11B1 109/4885
US-20050282880-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 MAP2K4 61/4885CYP19A1 1656/4885CYP11B1 187/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.